Skip to main content
. 2020 Dec 29;44(6 Suppl 2):S305–S315. doi: 10.1016/j.bj.2020.12.008

Fig. 2.

Fig. 2

Patients with highly expressed HAGLROS in NSCLC have worse prognosis. (A and B) Kaplan–Meier analysis was carried out to analyze the differences of relapse survival time and overall survival time between NSCLC patients with high expression of HAGLROS and with low expression of HAGLROS.